Hotbed/Location
Filter News
Found 736,789 articles
-
Johnson & Johnson’s Prostate Cancer Drug Extends Life While Spurring $5 Billion Market
6/2/2011
-
AVI BioPharma, Inc. CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company
6/2/2011
-
Insulet Corporation Announces Acquisition of Neighborhood Diabetes for $63 Million
6/2/2011
-
Silence Therapeutics plc to Close US Operations in Reorganization, Search on for New CEO
6/2/2011
-
ThermoGenesis Announces 510(k) Approval for Use of Res-Q in Preparation of Platelet Rich Plasma
6/2/2011
-
Covidien Announces U.S. 510(k) Clearance and European CE Mark Approval of Parietex(TM) Optimized Composite Mesh
6/2/2011
-
Teva Pharmaceutical Industries Limited Eyes Deals in India, Gets US OK for Generic Aricept
6/2/2011
-
Animas® Vibe™, the First Integrated Offering from Animas Corporation and DexCom, Receives European CE Mark Approval
6/2/2011
-
AlphaRx International Holdings Limited Terminates Its Chief Scientist and Chief Medical Officer for Cause
6/2/2011
-
Vaccine May Help Treat Advanced Melanoma: M. D. Anderson Cancer Center
6/2/2011
-
Cholesterol Drugs Tied to Lower Prostate Cancer Risk, Duke University School of Medicine Study
6/2/2011
-
New Technology Could Inspire Brain Implant For Detecting And Treating Seizures, University of Pittsburgh Study
6/2/2011
-
Ortho-McNeil Pharmaceutical, Inc. Ditches $625 Million Diabetes Drug Pact with Diamyd Medical AB
6/2/2011
-
Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic
6/2/2011
-
Saliva Test Can Show Infection in Babies, University of Alabama at Birmingham Study
6/2/2011
-
Development Could Double Flu Vaccine Supply: Vanderbilt University School of Medicine
6/2/2011
-
Zarlink Chip Designed Into Starkey Laboratories Inc.'s Wi Hearing Aids
6/2/2011
-
ReGen Biologics, Inc. Sues FDA Over Knee Implant
6/2/2011
-
GlaxoSmithKline and Theravance, Inc. Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD; Results Support Continuation of Development Program
6/2/2011
-
Theratechnologies Inc. Adopts New R&D Business Model to Strengthen Its Growth Potential; Cuts 24 Jobs
6/2/2011